Paula Jiménez Fonseca

Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry

Paula Jiménez Fonseca, Alberto Carmona‐Bayonas, Raquel Hernández et al. · British Journal of Cancer · 2017 · 103 citations · Full text

Medicine, Oncology, Chemotherapy +12

Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study

Akihito Kawazoe, Rui‐Hua Xu, Pilar García‐Alfonso et al. · Journal of Clinical Oncology · 2024 · 77 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Epithelial-Mesenchymal Transition Markers in the Differential Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors

José A. Galván, Aurora Astudillo, Aitana Vallina et al. · American Journal of Clinical Pathology · 2013 · 43 citations · Full text

Medicine, Oncology, Pathology +17

A phase II/III randomized double-blind study of octreotide acetate LAR with axitinib versus octreotide acetate LAR with placebo in patients with advanced G1-G2 NETs of non-pancreatic origin (AXINET trial-GETNE-1107).

Rocio García‐Carbonero, Marta Benavent, Paula Jiménez Fonseca et al. · Journal of Clinical Oncology · 2021 · 37 citations

Medicine, Oncology, Pharmacology +14

Prognostic Factors in Patients With Advanced Renal Cell Carcinoma

Carolina Muriel López, Emilio Esteban, José Pablo Berros et al. · Clinical Genitourinary Cancer · 2012 · 34 citations · Full text

Medicine, Oncology, Genitourinary Oncology +10